Your session is about to expire
← Back to Search
Estrogen tablet for Urinary Tract Infection
Study Summary
This trial aims to understand how well women with low estrogen levels adhere to different types of vaginal estrogen treatments for recurrent urinary tract infections. They will also study changes in vaginal skin using a specialized imaging technique and
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current number of participants being admitted to this clinical study?
"Indeed, details on clinicaltrials.gov highlight the ongoing patient recruitment for this trial. Initially listed on April 1st, 2024, and last modified on April 5th, 2024, the study aims to enroll a total of 111 participants from one site."
Are patients currently able to participate in this ongoing medical study?
"According to the details provided on clinicaltrials.gov, this particular research investigation is actively seeking eligible individuals. The trial was first published on April 1st, 2024 and underwent its most recent revision on April 5th, 2024."
Has the Estrogen tablet been certified by the FDA for use?
"The safety rating for the Estrogen tablet in this Phase 4 trial is categorized as a level 3 by our team at Power, indicating that the treatment has already obtained approval."
Share this study with friends
Copy Link
Messenger